MitraClip 30-Day Readmissions and Impact of Early Discharge: An Analysis from the Nationwide Readmissions Database 2016
Highlights
- • The overall 30-day MitraClip readmission rate is 13.5%.
- • Readmission rate among patients discharged early (<48 h) is 10.1%.
- • Early discharge (<48 h) post-MitraClip treatment is feasible and safe.
- • Special considerations for postprocedural complications and heart failure patients.
Abstract
Background/Purpose
Edge-to-edge mitral valve repair (MVR) using the MitraClip (Abbott Vascular, Santa Clara, CA), is now labeled for patients with degenerative and functional mitral regurgitation. Because this is a minimally invasive transcatheter procedure, patients are commonly discharged early post-procedure, yet rates and causes of early readmissions are unknown. This study aimed to evaluate underlying causes and trends of 30-day readmissions using the 2016 US Nationwide Readmissions Database (NRD) in patients discharged early after MVR with MitraClip.